rs150367317
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_147127.5(EVC2):c.913G>T(p.Ala305Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00045 in 1,614,192 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_147127.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVC2 | NM_147127.5 | c.913G>T | p.Ala305Ser | missense_variant | 8/22 | ENST00000344408.10 | NP_667338.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVC2 | ENST00000344408.10 | c.913G>T | p.Ala305Ser | missense_variant | 8/22 | 1 | NM_147127.5 | ENSP00000342144.5 | ||
EVC2 | ENST00000310917.6 | c.673G>T | p.Ala225Ser | missense_variant | 8/22 | 1 | ENSP00000311683.2 | |||
EVC2 | ENST00000475313.5 | n.673G>T | non_coding_transcript_exon_variant | 8/23 | 1 | ENSP00000431981.1 | ||||
EVC2 | ENST00000509670.1 | n.673G>T | non_coding_transcript_exon_variant | 9/23 | 1 | ENSP00000423876.1 |
Frequencies
GnomAD3 genomes AF: 0.000821 AC: 125AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000537 AC: 135AN: 251440Hom.: 2 AF XY: 0.000596 AC XY: 81AN XY: 135894
GnomAD4 exome AF: 0.000411 AC: 601AN: 1461880Hom.: 6 Cov.: 32 AF XY: 0.000444 AC XY: 323AN XY: 727240
GnomAD4 genome AF: 0.000821 AC: 125AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.000886 AC XY: 66AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 02, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jun 06, 2019 | The EVC2 c.[904T>A; c.913G>T]; p.[Phe302Ile; p.Ala305Ser] complex variant (rs138728350, rs150367317), to our knowledge, is not reported in the medical literature or gene specific databases. The individual variants are reported separately as benign or likely benign in ClinVar (Variation ID: 461811, 461812), but are found in cis in the Genome Aggregation Database with an overall allele frequency of 0.05% (145/282808 alleles, including 2 homozygotes) in the general population. The phenylalanine at codon 302 and the alanine at codon 305 are both highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that each variant is deleterious. Due to limited information, the clinical significance of the complex variant is uncertain at this time. - |
EVC2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 04, 2024 | The EVC2 c.913G>T variant is predicted to result in the amino acid substitution p.Ala305Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.078% of alleles in individuals of South Asian descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Ellis-van Creveld syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Sep 12, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 20, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at